Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial
出版年份 2013 全文链接
标题
Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial
作者
关键词
High grade glioma (HGG), Nimotuzumab, EGFR, Monoclonal antibody, Adult glioma, Anaplastic astrocytoma, Glioblastoma multiforme
出版物
BMC CANCER
Volume 13, Issue 1, Pages -
出版商
Springer Nature
发表日期
2013-06-19
DOI
10.1186/1471-2407-13-299
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma
- (2017) Sith Sathornsumetee et al. NEURO-ONCOLOGY
- EPIDERMAL GROWTH FACTOR RECEPTOR TARGETED THERAPIES FOR SOLID TUMOURS
- (2014) M Van den Eynde et al. ACTA CLINICA BELGICA
- Antiangiogenic therapies in glioblastoma multiforme
- (2012) Mairéad G McNamara et al. Expert Review of Anticancer Therapy
- Immunotherapy for Glioma
- (2012) Seunggu J. Han et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- Bivalent binding by intermediate affinity of nimotuzumab: A contribution to explain antibody clinical profile
- (2011) Greta Garrido et al. CANCER BIOLOGY & THERAPY
- Recent advancements in multimodality treatment of gliomas
- (2011) Mersiha Hadziahmetovic et al. Future Oncology
- A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas
- (2011) J. J. Raizer et al. NEURO-ONCOLOGY
- A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
- (2011) J. J. Raizer et al. NEURO-ONCOLOGY
- Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck
- (2010) Marta Osorio Rodríguez et al. CANCER BIOLOGY & THERAPY
- Epidermal Growth Factor Receptor Expression Identifies Functionally and Molecularly Distinct Tumor-Initiating Cells in Human Glioblastoma Multiforme and Is Required for Gliomagenesis
- (2010) S. Mazzoleni et al. CANCER RESEARCH
- Nimotuzumab for pediatric diffuse intrinsic pontine gliomas
- (2010) Maura Massimino et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies
- (2010) Benoit You et al. INVESTIGATIONAL NEW DRUGS
- Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin
- (2010) Melarkode S. Ramakrishnan et al. mAbs
- Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study
- (2010) W. K. A. Yung et al. NEURO-ONCOLOGY
- Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
- (2009) B. Neyns et al. ANNALS OF ONCOLOGY
- Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies
- (2009) A Diaz Miqueli et al. BRITISH JOURNAL OF CANCER
- Nimotuzumab, an Antitumor Antibody that Targets the Epidermal Growth Factor Receptor, Blocks Ligand Binding while Permitting the Active Receptor Conformation
- (2009) A. Talavera et al. CANCER RESEARCH
- Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity
- (2009) William Kells Boland et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Nimotuzumab in pediatric glioma
- (2009) Catherine Lam et al. Future Oncology
- Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
- (2009) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
- (2009) David M. Peereboom et al. JOURNAL OF NEURO-ONCOLOGY
- Oncogenic EGFR Signaling Networks in Glioma
- (2009) P. H. Huang et al. Science Signaling
- Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments
- (2008) A. A. Brandes et al. CLINICAL CANCER RESEARCH
- Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
- (2008) Paul D. Brown et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- (2008) Michael D. Prados et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma
- (2008) J. F. de Groot et al. JOURNAL OF NEURO-ONCOLOGY
- Current situation of Panitumumab, Matuzumab, Nimotuzumab and Zalutumumab
- (2007) Fernando Rivera et al. ACTA ONCOLOGICA
- A Phase I Dose-Escalation Study of Fractionated Stereotactic Radiosurgery in Combination With Gefitinib in Patients With Recurrent Malignant Gliomas
- (2007) Amanda L. Schwer et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started